Welcome!
Lonza Group AG
Covid-19
Lonza expands collaboration with Moderna for manufacturing of Covid-19 vaccine
The new production line is expected to be operational by the end of 2021.
June 02, 2021
M&A
Lonza to divest specialty ingredients business to Bain Capital and Cinven for $6.2 bil
The transaction is expected to close in 2H2021.
February 09, 2021
Covid-19
Lonza in manufacturing deal with Moderna for Covid-19 vaccine
The parties plan to produce up to 1 billion doses of the vaccine per year
May 01, 2020
Samsung looks beyond smartphones to next-gen biologics
(May 16): The Samsung brand is best known for its smartphones and wide-screen TVs. Yet behind the scenes, the conglomerate is also making a name as a contract manufacturer of complex medicines to treat diseases like cancer.
May 16, 2017